When Medications Don't Help: UNC Health on Epilepsy Surgery

UNC Health Talk has published a patient-facing piece titled "When Medications Don't Help: Surgery for Epilepsy," addressing the subset of epilepsy patients for whom antiseizure medications fail to control seizures and for whom operative treatment becomes the therapeutic option worth discussing.

The premise of the article sits squarely within established clinical reality. Roughly speaking, epilepsy specialists recognize that a meaningful proportion of patients do not achieve seizure freedom with medication alone, and international guidelines have long held that drug-resistant epilepsy warrants evaluation at a specialized epilepsy center. The UNC Health Talk article walks through what that evaluation and the surgical pathway involve, framed for patients and families rather than for the reading room.

For an EEG-focused audience, the piece is a useful reminder of where the electrophysiology lab fits in the surgical decision chain. Epilepsy surgery candidacy rests on concordant data, and scalp video-EEG monitoring is typically the first and most decisive step: prolonged recordings with seizure capture allow localization of the epileptogenic zone, classification of seizure type, and correlation of the electrographic onset with the semiology captured on video. Where scalp EEG and imaging fail to converge on a single resectable focus, the evaluation may proceed to intracranial recordings — stereotactically placed depth electrodes or subdural grids and strips — to map onset and functional cortex before resection. The specific montage details, cohort numbers, and institutional outcomes are not itemized in the accessible summary of the piece, and readers seeking those specifics should consult the full article at UNC Health Talk.

The article's core message for the monitoring unit is one that clinical neurophysiologists regularly repeat to referring clinicians: uncontrolled seizures on appropriate medication are not a reason to keep cycling indefinitely through drug regimens. They are a reason to refer. Surgical evaluation is not a last resort after every pharmacologic permutation has failed; it is the indicated next step once drug resistance declares itself, because each additional year of uncontrolled seizures carries consequences for cognition, safety, and quality of life that surgery, when successful, can arrest.

The piece also belongs to a broader genre of institutional communication that epilepsy centers have adopted: demystifying surgery for a patient population that historically underuses it. The gap between the number of patients who are surgical candidates and the number who ever reach an epilepsy center remains one of the field's persistent problems, and patient-education content from academic medical centers is one of the instruments for closing it. Articles of this kind typically cover the major operative options — resective surgery such as temporal lobectomy, disconnection procedures, and neuromodulatory devices — along with the workup that precedes any of them, though the available summary does not enumerate which of these the UNC piece details.

For neurophysiologists and EEG technologists, the practical takeaway is straightforward. Patients arriving with years of pharmacologically refractory seizures and no prior video-EEG monitoring represent referrals that arrived late. Every seizure captured in the monitoring unit with synchronized video, every localization decision made from an ictal onset pattern, and every intracranial implantation planned from that scalp data is part of the pathway that articles like this one try to make more familiar to the public.

UNC Health Talk's piece, framed around the moment medications stop helping, points patients toward that pathway. Whether the article's reach translates into earlier referrals to comprehensive epilepsy centers is the open question that institutional outreach programs of this sort are designed to answer.